• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

结直肠癌腹膜转移：当前临床数据的回顾与更新。

Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data.

机构信息

Clinic for General and Visceral Surgery, Hospital Barmherzige Brüder Regensburg, Germany.

Clinic for General and Visceral Surgery, Hospital Barmherzige Brüder Regensburg, Germany.

出版信息

Clin Colorectal Cancer. 2024 Dec;23(4):309-317. doi: 10.1016/j.clcc.2024.05.007. Epub 2024 May 21.

DOI:10.1016/j.clcc.2024.05.007
PMID:38879377
Abstract

The peritoneal metastasized colorectal cancer (pmCRC) represents a serious health problem worldwide with a special emphasis in the developed countries. Several guidelines recognize the role of multimodal therapy consisting of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment of pmCRC. New data suggests that some other factors, eg, tumor biology, immune profile, neoadjuvant chemotherapy may play a predictive role for the oncological outcome of these patients.

摘要

腹膜转移结直肠癌（pmCRC）是一个全球性的严重健康问题，在发达国家尤为突出。多项指南都承认细胞减灭术（CRS）联合腹腔热灌注化疗（HIPEC）的多模态治疗方案在 pmCRC 治疗中的作用。新的数据表明，其他一些因素，如肿瘤生物学、免疫特征、新辅助化疗等可能对这些患者的肿瘤学结局具有预测作用。

相似文献

1
Peritoneal Carcinomatosis in Colorectal Cancer: Review and Update of Current Clinical Data.结直肠癌腹膜转移：当前临床数据的回顾与更新。
Clin Colorectal Cancer. 2024 Dec;23(4):309-317. doi: 10.1016/j.clcc.2024.05.007. Epub 2024 May 21.
2
Direct surgery with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastases.对结直肠腹膜转移患者进行细胞减灭术和热灌注腹腔化疗的直接手术。
Eur J Surg Oncol. 2021 Nov;47(11):2865-2872. doi: 10.1016/j.ejso.2021.05.046. Epub 2021 Jun 3.
3
Patients with colorectal peritoneal metastases and high peritoneal cancer index may benefit from cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.结直肠腹膜转移且腹膜肿瘤指数较高的患者可能从细胞减灭术和腹腔热灌注化疗中获益。
Eur J Surg Oncol. 2020 Dec;46(12):2283-2291. doi: 10.1016/j.ejso.2020.07.039. Epub 2020 Aug 5.
4
Repeat Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Using Open and Closed Abdomen Techniques for Colorectal Peritoneal Metastases and Peritoneal Pseudomyxoma Recurrences: Results from Six French Expert Centers.采用开放和闭合腹部技术对结直肠癌腹膜转移和腹膜假黏液瘤复发进行重复细胞减灭术和热灌注化疗：来自六个法国专家中心的结果
Ann Surg Oncol. 2025 Jan;32(1):209-220. doi: 10.1245/s10434-024-16407-1. Epub 2024 Nov 4.
5
Synchronous Liver Resection, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Liver and Peritoneal Metastases: A Systematic Review and Meta-analysis.同步肝切除、细胞减灭术和腹腔内热灌注化疗治疗结直肠癌肝和腹膜转移：系统评价和荟萃分析。
Dis Colon Rectum. 2021 Jun 1;64(6):754-764. doi: 10.1097/DCR.0000000000002027.
6
Long-Term Outcomes following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis of Colorectal Origin.结直肠来源腹膜癌瘤细胞减灭术和腹腔热灌注化疗的长期结果。
Curr Oncol. 2024 Jun 25;31(7):3657-3668. doi: 10.3390/curroncol31070269.
7
Perioperative Systemic Chemotherapy, Cytoreductive Surgery, and Hyperthermic Intraperitoneal Chemotherapy in Patients With Colorectal Peritoneal Metastasis: Results of the Prospective Multicenter Phase 2 COMBATAC Trial.结直肠癌腹膜转移患者的围手术期全身化疗、细胞减灭术和腹腔热灌注化疗：前瞻性多中心 2 期 COMBATAC 试验的结果。
Clin Colorectal Cancer. 2018 Dec;17(4):285-296. doi: 10.1016/j.clcc.2018.07.011. Epub 2018 Jul 31.
8
[Construction and evaluation of a nomogram for predicting the prognosis of patients with colorectal cancer with peritoneal carcinomatosis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].[用于预测接受细胞减灭术加腹腔内热灌注化疗的结直肠癌伴腹膜转移患者预后的列线图的构建与评估]
Zhonghua Wei Chang Wai Ke Za Zhi. 2023 May 25;26(5):434-441. doi: 10.3760/cma.j.cn441530-20230309-00071.
9
Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Colorectal Cancer with Peritoneal Metastasis: A Single-Center Cohort Study.细胞减灭术和腹腔热灌注化疗治疗结直肠癌伴腹膜转移：单中心队列研究。
Medicina (Kaunas). 2024 Jun 27;60(7):1058. doi: 10.3390/medicina60071058.
10
Cytoreductive surgery plus hyperthermic intraoperative peritoneal chemotherapy for people with peritoneal metastases from colorectal, ovarian or gastric origin: A systematic review of randomized controlled trials.细胞减灭术联合腹腔内热灌注化疗治疗结直肠、卵巢或胃来源腹膜转移患者：随机对照试验的系统评价。
World J Surg. 2024 Jun;48(6):1385-1403. doi: 10.1002/wjs.12186. Epub 2024 Apr 24.

引用本文的文献

1
Tumor Deposits in Non-Metastatic Colorectal Cancer as a Risk Factor of Peritoneal Metastasis.非转移性结直肠癌中的肿瘤沉积物作为腹膜转移的危险因素
Int J Med Sci. 2025 Jun 23;22(13):3162-3173. doi: 10.7150/ijms.113099. eCollection 2025.